Activity of the Multikinase Inhibitor Dasatinib Against Ovarian Cancer Cells

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6605381
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Auranofin Displays Anticancer Activity Against Ovarian Cancer Cells Through FOXO3 Activation Independent of P53

International Journal of Oncology
Cancer ResearchOncology
2014English

Activity of PXD101, a Histone Deacetylase Inhibitor, in Preclinical Ovarian Cancer Studies

Molecular Cancer Therapeutics
Cancer ResearchOncology
2006English

Enzyme-Instructed Intracellular Molecular Self-Assembly to Boost Activity of Cisplatin Against Drug-Resistant Ovarian Cancer Cells

Angewandte Chemie
2015English

Redirecting Mouse T Hybridoma Against Human Breast and Ovarian Carcinomas: In Vivo Activity Against HER-2/neu Expressing Cancer Cells

British Journal of Cancer
Cancer ResearchOncology
2003English

Proapoptotic Activity of Achillea Membranacea Essential Oil and Its Major Constituent 1,8-Cineole Against A2780 Ovarian Cancer Cells

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2020English

Activity of Dasatinib, a Dual SRC/ABL Kinase Inhibitor, and IPI-504, a Heat Shock Protein 90 Inhibitor, Against Gastrointestinal Stromal Tumor-Associated PDGFRAD842V Mutation

Clinical Cancer Research
Cancer ResearchOncology
2008English

Synergistic Cytotoxic Effect of Sulindac and Pyrrolidine Dithiocarbamate Against Ovarian Cancer Cells

Oncology Reports
MedicineCancer ResearchOncology
2012English

Topotecan Synergizes With CHEK1 (CHK1) Inhibitor to Induce Apoptosis in Ovarian Cancer Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

The Tyrosine Kinase Inhibitor Dasatinib Induces a Marked Adipogenic Differentiation of Human Multipotent Mesenchymal Stromal Cells

PLoS ONE
Multidisciplinary
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy